title: Cost-Effectiveness Analysis of Panitumumab+Mfolfox over Bevacizumab+Mfolfox as a First-Line Treatment for Metastatic Colorectal Cancer Patients with Wild-Type Ras in Greece.
authors.affiliation: National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
authors.forename: G
authors.initials: G
authors.lastname: Kourlaba
authors.affiliation: Bioclinic Thessaloniki - Oncology Unit, Thesaloniki, Greece.
authors.forename: I
authors.initials: I
authors.lastname: Boukovinas
authors.affiliation: Laboratory of Tumor Cell Biology School of Medicine-University of Crete, Herakleion, Crete, Greece.
authors.forename: Z
authors.initials: Z
authors.lastname: Saridaki
authors.affiliation: AMGEN Hellas, Marousi, Greece.
authors.forename: V
authors.initials: V
authors.lastname: Papagiannopoulou
authors.affiliation: AMGEN Hellas, Marousi, Greece.
authors.forename: G
authors.initials: G
authors.lastname: Tritaki
authors.affiliation: National School of Public Health, Athens, Greece.
authors.forename: N
authors.initials: N
authors.lastname: Maniadakis